Advanced search
Publication Cover
Cancer Biology & Therapy Volume 15, 2014 - Issue 8
Submit an article Journal homepage
1,400
Views
32
CrossRef citations to date
0
Altmetric
Research Paper

Clodronate inhibits tumor angiogenesis in mouse models of ovarian cancer

Nicole M Reusser Department of Nanomedicine and Bioengineering; The University of Texas Health Science Center at Houston; Houston, TX USA; Department of Gynecologic Oncology and Reproductive Medicine; The University of Texas MD Anderson Cancer Center; Houston, TX USA
,
Heather J Dalton Department of Gynecologic Oncology and Reproductive Medicine; The University of Texas MD Anderson Cancer Center; Houston, TX USA
,
Sunila Pradeep Department of Gynecologic Oncology and Reproductive Medicine; The University of Texas MD Anderson Cancer Center; Houston, TX USA
,
Vianey Gonzalez-Villasana Department of Experimental Therapeutics; The University of Texas MD Anderson Cancer Center; Houston, TX USA
,
Nicholas B Jennings Department of Gynecologic Oncology and Reproductive Medicine; The University of Texas MD Anderson Cancer Center; Houston, TX USA
,
Hernan G Vasquez Department of Internal Medicine; The University of Texas Health Science Center at Houston; Houston, TX USA
,
Yunfei Wen Department of Gynecologic Oncology and Reproductive Medicine; The University of Texas MD Anderson Cancer Center; Houston, TX USA
,
Rajesh Rupaimoole Department of Gynecologic Oncology and Reproductive Medicine; The University of Texas MD Anderson Cancer Center; Houston, TX USA
,
Archana S Nagaraja Department of Gynecologic Oncology and Reproductive Medicine; The University of Texas MD Anderson Cancer Center; Houston, TX USA
,
Kshipra Gharpure Department of Gynecologic Oncology and Reproductive Medicine; The University of Texas MD Anderson Cancer Center; Houston, TX USA
,
Takahito Miyake Department of Gynecologic Oncology and Reproductive Medicine; The University of Texas MD Anderson Cancer Center; Houston, TX USA
,
Jie Huang Department of Gynecologic Oncology and Reproductive Medicine; The University of Texas MD Anderson Cancer Center; Houston, TX USA
,
Wei Hu Department of Gynecologic Oncology and Reproductive Medicine; The University of Texas MD Anderson Cancer Center; Houston, TX USA
,
Gabriel Lopez-Berestein Department of Nanomedicine and Bioengineering; The University of Texas Health Science Center at Houston; Houston, TX USA; Department of Experimental Therapeutics; The University of Texas MD Anderson Cancer Center; Houston, TX USA; Department of Cancer Biology; The University of Texas MD Anderson Cancer Center; Houston, TX USA; Center for RNA Interference and Non-Coding RNA; The University of Texas MD Anderson Cancer Center; Houston, TX USA
&
Anil K Sood Department of Gynecologic Oncology and Reproductive Medicine; The University of Texas MD Anderson Cancer Center; Houston, TX USA; Department of Cancer Biology; The University of Texas MD Anderson Cancer Center; Houston, TX USA; Center for RNA Interference and Non-Coding RNA; The University of Texas MD Anderson Cancer Center; Houston, TX USACorrespondence[email protected]
 show all
Pages 1061-1067 | Received 26 Mar 2014, Accepted 09 May 2014, Published online: 19 May 2014

References

  • Hall M, Gourley C, McNeish I, Ledermann J, Gore M, Jayson G, Perren T, Rustin G, Kaye S. Targeted anti-vascular therapies for ovarian cancer: current evidence. Br J Cancer 2013; 108:250 - 8; http://dx.doi.org/10.1038/bjc.2012.541; PMID: 23385789
  • Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature 2011; 473:298 - 307; http://dx.doi.org/10.1038/nature10144; PMID: 21593862
  • Través PG, Luque A, Hortelano S. Macrophages, inflammation, and tumor suppressors: ARF, a new player in the game. Mediators Inflamm 2012; 2012:568783; http://dx.doi.org/10.1155/2012/568783; PMID: 23316105
  • Welford AF, Biziato D, Coffelt SB, Nucera S, Fisher M, Pucci F, Di Serio C, Naldini L, De Palma M, Tozer GM, et al. TIE2-expressing macrophages limit the therapeutic efficacy of the vascular-disrupting agent combretastatin A4 phosphate in mice. J Clin Invest 2011; 121:1969 - 73; http://dx.doi.org/10.1172/JCI44562; PMID: 21490397
  • DeNardo DG, Brennan DJ, Rexhepaj E, Ruffell B, Shiao SL, Madden SF, Gallagher WM, Wadhwani N, Keil SD, Junaid SA, et al. Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. Cancer Discov 2011; 1:54 - 67; http://dx.doi.org/10.1158/2159-8274.CD-10-0028; PMID: 22039576
  • Russell RG. Bisphosphonates: the first 40 years. Bone 2011; 49:2 - 19; http://dx.doi.org/10.1016/j.bone.2011.04.022; PMID: 21555003
  • Zeisberger SM, Odermatt B, Marty C, Zehnder-Fjällman AH, Ballmer-Hofer K, Schwendener RA. Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach. Br J Cancer 2006; 95:272 - 81; http://dx.doi.org/10.1038/sj.bjc.6603240; PMID: 16832418
  • Baer C, Squadrito ML, Iruela-Arispe ML, De Palma M. Reciprocal interactions between endothelial cells and macrophages in angiogenic vascular niches. Exp Cell Res 2013; 319:1626 - 34; http://dx.doi.org/10.1016/j.yexcr.2013.03.026; PMID: 23542777
  • Giger EV, Castagner B, Leroux JC. Biomedical applications of bisphosphonates. J Control Release 2013; 167:175 - 88; http://dx.doi.org/10.1016/j.jconrel.2013.01.032; PMID: 23395668
  • Ribatti D, Maruotti N, Nico B, Longo V, Mangieri D, Vacca A, Cantatore FP. Clodronate inhibits angiogenesis in vitro and in vivo. Oncol Rep 2008; 19:1109 - 12; PMID: 18425365
  • Lamalice L, Le Boeuf F, Huot J. Endothelial cell migration during angiogenesis. Circ Res 2007; 100:782 - 94; http://dx.doi.org/10.1161/01.RES.0000259593.07661.1e; PMID: 17395884
  • Hafeman SD, Varland D, Dow SW. Bisphosphonates significantly increase the activity of doxorubicin or vincristine against canine malignant histiocytosis cells. Vet Comp Oncol 2012; 10:44 - 56; http://dx.doi.org/10.1111/j.1476-5829.2011.00274.x; PMID: 22236140
  • Diel IJ, Fogelman I, Al-Nawas B, Hoffmeister B, Migliorati C, Gligorov J, Väänänen K, Pylkkänen L, Pecherstorfer M, Aapro MS. Pathophysiology, risk factors and management of bisphosphonate-associated osteonecrosis of the jaw: Is there a diverse relationship of amino- and non-aminobisphosphonates?. Crit Rev Oncol Hematol 2007; 64:198 - 207; http://dx.doi.org/10.1016/j.critrevonc.2007.07.005; PMID: 17855108
  • Winter MC, Coleman RE. Bisphosphonates in the adjuvant treatment of breast cancer. Clin Oncol (R Coll Radiol) 2013; 25:135 - 45; http://dx.doi.org/10.1016/j.clon.2012.10.010; PMID: 23207072
  • Zhu J, Zheng Y, Zhou Z. Oral adjuvant clodronate therapy could improve overall survival in early breast cancer: results from an updated systematic review and meta-analysis. Eur J Cancer 2013; 49:2086 - 92; http://dx.doi.org/10.1016/j.ejca.2013.01.021; PMID: 23452992
  • Saad F, Colombel M. Management of castration-resistant prostate cancer: bisphosphonates and emerging therapies. Expert Rev Anticancer Ther 2010; 10:1991 - 2002; http://dx.doi.org/10.1586/era.10.191; PMID: 21110764
  • Rodrigues P, Hering FO, Meller A. Adjuvant effect of IV clodronate on the delay of bone metastasis in high-risk prostate cancer patients: a prospective study. Cancer Res Treat 2011; 43:231 - 5; http://dx.doi.org/10.4143/crt.2011.43.4.231; PMID: 22247708
  • Marchetti C, Pisano C, Facchini G, Bruni GS, Magazzino FP, Losito S, Pignata S. First-line treatment of advanced ovarian cancer: current research and perspectives. Expert Rev Anticancer Ther 2010; 10:47 - 60; http://dx.doi.org/10.1586/era.09.167; PMID: 20014885

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.